Protective role of taurine against genotoxic damage in mice treated with methotrexate and tamoxfine

Environmental Toxicology and Pharmacology

Volumn 31, Issue 1, 2011, Pages 143-152

  Alam, Sally S ^a   Hafiz, Nagla A ^a   Abd El Rahim, Abeer H ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Anti neoplastic; Chromosomal aberration; DNA fragmentation; Taurine

Indexed keywords

GLUTATHIONE; METHOTREXATE; TAMOXIFEN; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STRUCTURE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA FRAGMENTATION; DRUG EFFECT; DRUG MECHANISM; GENOTOXICITY; GERM CELL; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOMATIC CELL; SPERMATOZOON ABNORMALITY; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY;

ANDROGENS; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTIMUTAGENIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; DNA DAMAGE; DNA FRAGMENTATION; ELECTROPHORESIS, AGAR GEL; GERM CELLS; GLUTATHIONE; LIVER; MALE; METHOTREXATE; MICE; SPERM MOTILITY; SPERMATOCYTES; SULFHYDRYL COMPOUNDS; TAMOXIFEN; TAURINE;

ANIMALIA; MUS;

EID: 78650215226     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2010.10.001     Document Type: Article

References (59)

1. Alvarez J.G., Storey B.T. Taurine, hypotaurine, epinephrine and albumin inhibit lipid peroxidation in rabbit spermatozoa and protect against loss of motility. Biol. Reprod. 1983, 29:548-555.
2. Alvarez J.G., Storey B.T. Spontaneous lipid peroxidation in rabbit epididymal spermatozoa: its effects on sperm motility. Biol. Reprod. 1982, 27:1102-1108.
3. Arnon J., Meirow D., Roness H.L., Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum. Reprod. Update 2001, 7:394-403.
4. Aziz A.H.A., Shouman S.A., Attia A.S., Saad S.F. A study on the reproductive toxicity of erythrosine in male mice. Pharmacol. Res. 1997, 35:457-462.
5. Babiak R.M., Campello A.P., Carnieri E.G., Oliveira M.B. Methotrexate: pentose cycle and oxidative stress. Cell Biochem. Funct. 1998, 16:283-293.
6. Bidri M., Choay P. Taurine: a particular aminoacid with multiple functions. Ann. Pharm. Fr. 2003, 61(November (6)):385-391.
7. Branda R.F., Neill J.P.O., Brooks E.M., Powden C., Naud S.J., Nicklas J.A. The effect of dietary folic acid deficiency on the cytotoxic and mutagenic responses to methyl methanesulfonate in wild-type and in 3-methyladenine DNA glycosylase-deficient Aag null mice. Mutat. Res. 2007, 615:12-17.
8. Çetiner M., Şener G., Şehirli A.Ö., Ekşioǧlu-Demiralp E., Ercan F., Şirvanc S., Gedik N., Akpulat S., Tecimer T., Yeǧen B.Ç. Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death. Toxicol. Appl. Pharmacol. 2005, 209:39-50.
9. Choudhury R.C., Ghosh S.K., Palo A.K. Potential transmission of the cytogenetic toxic effects of methotrexate in the male germline cells of Swiss mice. Environ. Toxicol. Pharmacol. 2001, 10:81-88.
10. Choudhury R.C., Ghosh S.K., Palo A.K. Cytogenetic toxicity of methotrexate in mouse bone marrow. Environ. Toxicol. Pharmacol. 2000, 8:191-196.
11. Choudhury R.C., Palo A.K. Modulatory effects of caffeine on methotrexate induced cytogenotoxicity in mouse bone marrow. Environ. Toxicol. Pharmacol. 2004, 15:79-85.
12. da Costa G.G., Marques M.M., Fu X., Churchwell M.I., Wang Y.-P., Doerge D.R., Beland F.A. Effect of N,N-didesmethyltamoxifen upon DNA adduct formation by tamoxifen and a-hydroxytamoxifen. Cancer Lett. 2007, 257:191-198.
13. Dadhania V.P., Tripathi D.N., Vikram A., Ramarao P., Jena G.B. Intervention of α-lipoic acid ameliorates methotrexate-induced oxidative stress and genotoxicity: a study in rat intestine. Chem. Biol. Interact. 2010, 183(January (1)):85-97.
14. Ellman G. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-76.
15. Evans E.P., Breckon G., Ford C.E. An air-drying method for meiotic preparations for mammalian testes. Cytogenetics 1964, 3:289-294.
16. Freib B., Higdon J. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J. Nutr. 2003, 133:3275-3284.
17. Goto E., Tomojiri S., Okamoto I., Tanaka K. Methotrexate poisoning with acute hepatorenal dysfunction. J. Toxicol. Clin. Toxicol. 2001, 39:101-104.
18. Grosflam J., Weinblatt M.E. Methotrexate: mechanism of action, pharmacokinetics, clinical indications, and toxicity. Curr. Opin. Rheumatol. 1991, 3(3):363-368.
19. Han X., Liehr J.G. Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res. 1992, 52:1360-1363.
20. Havsteen B.H. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 2002, 96:67-202.
21. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 1992, 72:101-163.
22. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Pharmaceutical Drugs 1990, vol. 50. IARC Scientific Publication, IARC, Lyon, France, p. 415.
23. Jahovic N., Cevik H., Sehirli A.O., Yeǧen B.C., Sener G. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J. Pineal Res. 2003, 34(May (4)):282-287.
24. Jordan V.C. Effect of tamoxifen (ICI 46, 474) on initiation and growth of DMBA-induced rat mammary carcinomata. Eur. J. Cancer 1976, 12:419-424.
25. Jordan V.C. Tamoxifen: a most unlikely pioneering medicine. Nat. Rev. Drug Discov. 2003, 2:205-213.
26. Jordan V.C., Allen K.E. Evaluation of the antitumour activity of the nonsteroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model. Eur. J. Cancer 1980, 16:39-251.
27. Karki A., Mantyla E., Hirsimaki Y., Karlsson S., Toikkanen S., Hirsimaki P. Comparison of the effects of tamoxifen and toremifene on rat hepatocarcinogenesis. Arch. Toxicol. 2000, 74:249-256.
28. Marselos M., Vainio H. Carcinogenic properties of pharmaceutical agents evaluated in the IARC monographs programme. Carcinogenesis 1991, 12(10):1751-1766.
29. Miyazaki J., Kawai K., Hayashi H., Onozawa M., Tsukamoto S., Miyanaga N., Hinotsu S., Shimazui T., Akaza H. The limited efficacy of methotrexate, actinomycin D and cisplatin (MAP) for patients with advanced testicular cancer. Jpn. J. Clin. Oncol. 2003, 33:391-395.
30. Moorthy B., Sriram P., Randerath E., Randerath K. Effect of cytochrome p450 inducers on tamoxifen genotoxicity in female mice in vivo. Biochem. Pharmacol. 1997, 53:663-669.
31. Mrsny R.J., Waxman L., Meizel S. Taurine maintains and stimulates motility of hamster sperm during capacitation in vitro. J. Exp. Zool. 2005, 210(1):123-128.
32. Muralidhara B.S. Early oxidative stress in testes and epididymal sperm in streptozotocin-induced diabetic mice: its progression and genotoxic consequences. Reprod. Toxicol. 2007, 23:578-587.
33. Oktar S., Gökçe A., Aydin M., Davarci M., Meydan S., Öztürk O.H., Koç A. Beneficial effect of erdosteine on methotrexate-induced testicular toxicity in mice. Toxicol. Ind. Health 2010, 26(May).
34. Ortiz Z., Shea B., Suarez-Almazor M.E., Moher D., Wells G.A., Tugwell P. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A meta analysis of randomized controlled trials. J. Rheumatol. 1998, 25(1):36-43.
35. Padmalatha Rai S., Vijayalaxmi K.K. Tamoxifen citrate induced sperm shape abnormalities in the in vivo mouse. Mutat. Res. 2001, 492:1-6.
36. Padmanabhan S., Tripathi D.N., Vikram A., Ramarao P., Jena G.B. Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid. Mutat. Res. 2009, 673:43-52.
37. Paradones C.E., Illera V.A., Peckham D., Stunz L.L., Ashman R.F. Regulation of apoptosis in vitro in mature spleen T cell. J. Immunol. 1993, 151:3521.
38. Potter G.A., McCague R., Jarman M. A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism. Carcinogenesis 1994, 15:439-442.
39. Preston R.J., Au W., Bender M.A., Brewen J.G., Carrano A.V., Heddle J.A., McFee A.F., Wolff S., Wassom A.F. Mammalian in vivo and in vitro cytogenetic assays: a report of the US EPA's Gene-Tox Program. Mut. Res. 1981, 87:143-188.
40. Redmond H.P., Wang J.H., Bouchier-Hayes D. Taurine attenuates nitric oxide and reactive oxygen intermediate dependent hepatocyte injury. Arch. Surg. 1996, 131:1280-1287.
41. Saad S.Y., Al-Rikabi A.C. Protection effects of taurine supplementation against cisplatin-induced nephrotoxicity in rats. Chemotherapy 2002, 48:42-48.
42. Sadzuka Y., Matsuura M., Sonobe T. The effect of taurine, a novel biochemical modulator, on the antitumor activity of doxorubicin. Biol. Pharm. Bull. 2009, 32(9):1584-1587.
43. Savage J.R.K. Classification and relationship of induced chromosomal structural changes. J. Med. Genet. 1975, 12:103-122.
44. Schaffer S., Azuma J., Takahashi K., Mozaffari M. Why is taurine cytoprotective?. Adv. Exp. Med. Biol. 2003, 26:307-321.
45. Seigers R., Schagen S.B., Beerling W., Boogerd W., Van Tellingen O., Van Dam F.S.A.M., Koolhaas J.M., Buwalda B. Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav. Brain Res. 2008, 186:168-175.
46. Selvakumar E., Prahalathan C., Sudharsan P.T., Varalakshmi P. Chemoprotective effect of lipoic acid against cyclophosphamide-induced changes in the rat sperm. Toxicology 2006, 217(January (1)):71-78.
47. Sikka S.C. Oxidative stress and role of antioxidants in normal and abnormal sperm function. Front. Biosci. 1996, 1:e78-e86.
48. Styles J.A., Davies A., Davies R., White I.N.H., Smith L.L. Clastogenic and aneugenic effects of tamoxifen and some of its analogues in hepatocytes from dosed rats and in human lymphoblastoid cells transfected with human p450 cDNAs (MCL-5 cells). Carcinogenesis 1997, 18:303-313.
49. Styles J.A., Davies A., Lim C.K., deMatteis F., Stanley L.A., White I.N.H., Yuan Z.X., Smith L.L. Genotoxicity of tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome-p450S. Carcinogenesis 1994, 15:5-9.
50. Tabassum H., Parvez S., Rehman H., Dev Banerjee B., Siemen D., Raisuddin S. Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice. Hum. Exp. Toxicol. 2007, 26(June (6)):509-518.
51. Tabassum H., Rehman H., Banerjee B.D., Raisuddin S., Parvez S. Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice. Clin. Chim. Acta 2006, 370:129-136.
52. Valko M., Izakovic M., Mazur M., Rhodes C.J., Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem. 2004, 266(1-2):37-56.
53. Vancutsem P.M., Lazarus P., Williams G.M. Frequent and specific mutations of rat p53 gene in hepatocarcinoma induced by tamoxifen. Cancer Res. 1994, 54:3864-3867.
54. Veronesi U., Bonadonna G., Valagussa P. Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer. J. Clin. Oncol. 2008, 26:342-344.
55. Vijayalaxmi K.K., Padmalatha Rai S. Studies on the genotoxicity of tamoxifen citrate in mouse bone marrow cells. Mutat. Res. 1996, 368:109-114.
56. Wright C.E., Lin T.T., Syurman J.A., Gaull G.E. Taurine scavenges oxidized chlorine in biological systems. Taurine: Biological Actions and Clinical Perspectives 1985, 137-147. Alan R Liss Inc., New York. S.S. Oja (Ed.).
57. Wright C.E., Tallan H.H., Lin Y.Y., Gaull G.E. Taurine: biological update. Ann. Rev. Biochem. 1986, 55:427-453.
58. Wyrobek A.J., Bruce W.R. Chemical induction of sperm abnormalities in mice. Proc. Natl. Acad. Sci. U.S.A. 1975, 72:4425-4429.
59. Zhao N., Wang L., Mou H.Y., Liang M., Yue W. Synergism and attenuation effects of taurine on cyclophosphamide. Ai Zheng 2009, 28(March (3)):244-248.